Bernstein Harold
President, R&D & CMO
Bernstein Harold has filed 15 SEC Form 4 filings (45 transaction rows) across 1 company, with disclosures dating back to 2025. 15 of those filings fall inside the rolling window. Most recent filing: Oct 2, 2026.
On the most recent filing, Bernstein Harold is listed as President, R&D & CMO at Maze Therapeutics, Inc. Inside the rolling window, Bernstein Harold reported no open-market purchases and 17 open-market sales totaling $9.5M in MAZE. The largest disclosed transaction in the window is a sale of 45,000 MAZE shares on Dec 29, 2025, worth $1.8M.
Companies traded
Other insiders at MAZE
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$9.5M
reported sales (SEC code S)
Companies
1
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| MAZE | President, R&D & CMO | Sale | 16,141 | $435K | Oct 2 | SEC ↗ | |
| MAZE | President, R&D & CMO | Sale | 9,705 | $255K | Sep 8 | SEC ↗ | |
| MAZE | President, R&D & CMO | Sale | 5,106 | $135K | Sep 4 | SEC ↗ | |
| MAZE | President, R&D & CMO | Sale | 5,189 | $135K | Sep 4 | SEC ↗ | |
| MAZE | President, R&D & CMO | Sale | 16,141 | $426K | Sep 3 | SEC ↗ | |
| MAZE | President, R&D & CMO | Sale | 16,142 | $446K | Aug 14 | SEC ↗ | |
| MAZE | President, R&D & CMO | Sale | 14,609 | $437K | Jul 2 | SEC ↗ | |
| MAZE | President, R&D & CMO | Sale | 14,853 | $381K | Jun 3 | SEC ↗ | |
| MAZE | President, R&D & CMO | Sale | 15,000 | $393K | May 18 | SEC ↗ | |
| MAZE | President, R&D & CMO | Sale | 15,000 | $442K | Apr 2 | SEC ↗ | |
| MAZE | President, R&D & CMO | Sale | 15,000 | $736K | Mar 20 | SEC ↗ | |
| MAZE | President, R&D & CMO | Sale | 30,000 | $1.5M | Mar 12 | SEC ↗ | |
| MAZE | President, R&D & CMO | Sale | 15,000 | $690K | Feb 4 | SEC ↗ | |
| MAZE | President, R&D & CMO | Sale | 25,156 | $1.0M | Jan 9 | SEC ↗ | |
| MAZE | President, R&D & CMO | Sale | 4,432 | $179K | Jan 6 | SEC ↗ | |
| MAZE | President, R&D & CMO | Sale | 412 | $16K | Jan 6 | SEC ↗ | |
| MAZE | President, R&D & CMO | Sale | 45,000 | $1.8M | Dec 31 | SEC ↗ |
Frequently asked questions
How many SEC Form 4 filings has Bernstein Harold made?
Bernstein Harold has filed 15 SEC Form 4 filings (45 transaction rows) across 1 company since 2025.
Which companies does Bernstein Harold trade?
Bernstein Harold has filed SEC Form 4 disclosures for 1 company, including MAZE.
When was Bernstein Harold's most recent SEC Form 4 filing?
Bernstein Harold's most recent SEC Form 4 filing on Tracefour is dated Oct 2, 2026.
What is Bernstein Harold's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Bernstein Harold is listed as President, R&D & CMO.
What is Bernstein Harold's total buy and sell value in the current window?
Inside the rolling retention window, Bernstein Harold bought $0 and sold $9.5M based on SEC Form 4 filings.
What was Bernstein Harold's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 45,000 MAZE shares on 2025-12-29, worth $1.8M, per SEC Form 4 filings.